Wordt geladen...

拓扑替康用于小细胞肺癌维持/巩固治疗和挽救治疗的疗效比较

BACKGROUND AND OBJECTIVE: How to prolong progression free survival (PFS) and overall survival (OS) of patients with small cell lung cancer (SCLC) has been one of the hottest issues. We retrospectively reviewed our data to compare the survival of immediate with delayed topotecan after first-line ther...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Zhongguo Fei Ai Za Zhi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 中国肺癌杂志编辑部 2010
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000537/
https://ncbi.nlm.nih.gov/pubmed/20673518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2010.03.05
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!